382150 — OncoCross Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩87bn
- KR₩68bn
- KR₩370m
Annual cashflow statement for OncoCross Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -10,204 | -4,214 | -6,483 | -8,929 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 755 | -702 | 189 | 1,388 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 881 | -428 | 364 | -675 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -8,200 | -4,906 | -5,524 | -7,405 |
| Capital Expenditures | -341 | -24.7 | -174 | -3,326 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 8,613 | -918 | -469 | -14,930 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 8,272 | -943 | -642 | -18,255 |
| Financing Cash Flow Items | — | — | -651 | -3.34 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1,422 | 14,297 | 9,857 | 13,093 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 1,541 | 8,450 | 3,700 | -12,545 |